Takeda Presents New Phase 3 Data Showing Oveporexton Improves Daily Functioning, Cognition, and Sleep in Narcolepsy Type 1 Takeda has unveiled additional findings from its pivotal Phase 3 clinical development program for oveporexton (TAK-861) at SLEEP 2026, highlighting the investigational…
Incyte Reports Positive Phase 3 frontMIND Results Showing Tafasitamab and Lenalidomide Plus R-CHOP Improves Outcomes in High-Risk DLBCL and HGBL Incyte has announced positive results from its pivotal Phase 3 frontMIND clinical trial, demonstrating that the addition of tafasitamab and…
BeOne Medicines Showcases Promising Hematology Pipeline Data at EHA 2026, Highlighting Advances in BTK Degradation and Time-Limited Therapies BeOne Medicines Ltd., a global oncology company focused on developing innovative treatments for cancer and hematologic malignancies, has unveiled a series of…
Zetagen Therapeutics Reports Promising Phase 2a Results for Investigational ZetaMet™ in Metastatic Breast Cancer Patients With Lytic Bone Lesions Zetagen Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative therapies for primary and metastatic breast cancer, has released updated preliminary…
BeOne Medicines Highlights Long-Term BRUKINSA Benefits in Older CLL Patients at EHA 2026 BeOne Medicines Ltd., a global oncology company dedicated to advancing innovative cancer therapies, has announced the presentation of significant new clinical and real-world evidence supporting the long-term…
Anocca Doses First Patients in VIDAR-1 Trial of ANOC-001 TCR-T Therapy for KRAS-Mutated Pancreatic Cancer Anocca AB, a clinical-stage biotechnology company focused on the development of advanced T-cell immunotherapies, has announced a major milestone in its clinical development efforts with…
Galderma Global Survey Reveals Rising Demand for Long-Lasting, Natural-Looking Anti-Wrinkle Treatments Galderma has unveiled the results of a major international survey examining the expectations, preferences, and experiences of both patients and healthcare professionals (HCPs) regarding anti-wrinkle aesthetic treatments. Conducted across…
Adaptyx Biosciences Presents First-In-Human Continuous Multi-Day Free Cortisol Data from Wearable Sensor at ADA, Showing Time-Resolved Hormone Signals for Metabolic and Health Insights Adaptyx Biosciences, a Stanford University spinout focused on continuous molecular biosensing technologies, has reported a major clinical…
Ignite Proteomics Launches Prospective 10,000-Patient Oncology Registry to Assess Functional Proteomics in Cancer Therapy Selection Ignite Proteomics, LLC (“Ignite Proteomics”), a subsidiary of Aditxt, Inc. (NASDAQ: ADTX), has announced the launch of a large-scale prospective oncology registry designed to advance…
Beyond Anti-Aging: AV Laboratories Elevates Amino Acids as the Core of Science-Driven Skin Longevity At the AVL Molecular Research Center at the University of Colorado Boulder, AV Laboratories is conducting in-depth studies on skin cell biology to better understand the…
Azafaros Announces Publication of Phase 2 RAINBOW Study Results for Nizubaglustat in Molecular Genetics and Metabolism Journal Azafaros, a privately held biotechnology company focused on developing therapies for lysosomal storage disorders (LSDs) with a particular emphasis on neurological manifestations, has…
NEJM Publishes ASCERTAIN-V Trial Results of First All-Oral Decitabine-Cedazuridine Plus Venetoclax Regimen in AML Taiho Oncology, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for hematologic malignancies and solid tumors, has announced the publication of results from…